GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
1-Year Est. Return 49.13%
This Quarter Est. Return
1 Year Est. Return
+49.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$287M
AUM Growth
-$23.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1
+$11.8M
2
+$7.12M
3
+$6.11M
4
CGON icon
CG Oncology
CGON
+$5.84M
5
CRBP icon
Corbus Pharmaceuticals
CRBP
+$5.34M

Top Sells

1
+$11.1M
2
+$9.11M
3
+$6.65M
4
TGTX icon
TG Therapeutics
TGTX
+$5.78M
5
INSM icon
Insmed
INSM
+$5.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN icon
1
Biohaven
BHVN
$874M
$17M 5.33%
490,000
+205,000
MLTX icon
2
MoonLake Immunotherapeutics
MLTX
$677M
$13.2M 4.13%
300,000
SLNO icon
3
Soleno Therapeutics
SLNO
$2.56B
$12.2M 3.83%
300,000
+100,000
AXSM icon
4
Axsome Therapeutics
AXSM
$6.96B
$12.1M 3.78%
150,000
-60,000
ASND icon
5
Ascendis Pharma
ASND
$12B
$11.8M 3.7%
+86,721
PCVX icon
6
Vaxcyte
PCVX
$5.45B
$11.3M 3.55%
150,000
+55,000
CRNX icon
7
Crinetics Pharmaceuticals
CRNX
$3.77B
$10.7M 3.37%
240,000
+40,000
ROIV icon
8
Roivant Sciences
ROIV
$14.1B
$10.6M 3.31%
1,000,000
-300,000
CATX icon
9
Perspective Therapeutics
CATX
$163M
$9.22M 2.89%
925,000
+325,000
TGTX icon
10
TG Therapeutics
TGTX
$5.12B
$8.89M 2.79%
500,000
-325,000
SRPT icon
11
Sarepta Therapeutics
SRPT
$1.85B
$8.69M 2.72%
55,000
-70,000
CGON icon
12
CG Oncology
CGON
$3.03B
$8.21M 2.57%
260,000
+185,000
CRBP icon
13
Corbus Pharmaceuticals
CRBP
$179M
$7.92M 2.48%
175,000
+118,059
VRDN icon
14
Viridian Therapeutics
VRDN
$2.62B
$7.65M 2.39%
587,708
-37,292
SNDX icon
15
Syndax Pharmaceuticals
SNDX
$1.31B
$7.19M 2.25%
350,000
+200,000
IMVT icon
16
Immunovant
IMVT
$4.07B
$6.86M 2.15%
260,000
+135,000
TARS icon
17
Tarsus Pharmaceuticals
TARS
$2.9B
$6.39M 2%
235,000
-65,000
PHAT icon
18
Phathom Pharmaceuticals
PHAT
$943M
$6.18M 1.94%
600,000
+115,000
RZLT icon
19
Rezolute
RZLT
$977M
$6.11M 1.91%
+1,421,501
OLMA icon
20
Olema Pharmaceuticals
OLMA
$573M
$5.95M 1.86%
550,000
+350,000
SYRE icon
21
Spyre Therapeutics
SYRE
$1.75B
$5.88M 1.84%
250,237
+150,237
ALNY icon
22
Alnylam Pharmaceuticals
ALNY
$58.5B
$5.47M 1.71%
22,500
-37,500
APLS icon
23
Apellis Pharmaceuticals
APLS
$2.44B
$5.18M 1.62%
135,000
+5,000
VKTX icon
24
Viking Therapeutics
VKTX
$4.16B
$5.04M 1.58%
95,000
+21,998
RYTM icon
25
Rhythm Pharmaceuticals
RYTM
$6.69B
$4.82M 1.51%
117,388
-7,612
1
2 3 4